Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA

抗药性 卵巢癌 基因组不稳定性 DNA测序 DNA 癌症的体细胞进化 基因 计算生物学 生物 药品 浆液性液体 遗传学 癌症 表型 克隆选择 癌症研究 基因组DNA 浆液性卵巢癌 DNA损伤 下调和上调 靶向治疗 DNA修复 基因组 选择(遗传算法) 基因复制 转录组 卵巢 深度测序 互补DNA 细胞 否定选择
作者
Marc Williams,Ignacio Vázquez-Garćıa,Grittney Tam,Michelle Wu,Nancy Varice,Eliyahu Havasov,Hongyu Shi,Duaa H. Al-Rawi,Gryte Satas,Hannah Lees,Jake June-Koo Lee,Matthew Myers,Matthew Zatzman,Nicole Rusk,Emily Ali,Ronak Shah,Michael F. Berger,Neeman Mohibullah,Yulia Lakhman,S Dennis
出处
期刊:Nature [Nature Portfolio]
卷期号:647 (8090): 757-765 被引量:14
标识
DOI:10.1038/s41586-025-09580-0
摘要

Emergence of drug resistance is the main cause of therapeutic failure in patients with high-grade serous ovarian cancer (HGSOC)1. To study drug resistance in patients, we developed CloneSeq-SV, which combines single-cell whole-genome sequencing2 with targeted deep sequencing of clone-specific genomic structural variants in time-series cell-free DNA. CloneSeq-SV exploits tumour clone-specific structural variants as highly sensitive endogenous cell-free DNA markers, enabling the relative abundance measurements and evolutionary analysis of co-existing clonal populations over the therapeutic time course. Here, using this approach, we studied 18 patients with HGSOC over a multi-year period from diagnosis to recurrence and showed that drug resistance typically arose from selective expansion of a single or small subset of clones present at diagnosis. Drug-resistant clones frequently showed interpretable and distinctive genomic features, including chromothripsis, whole-genome doubling, and high-level amplifications of oncogenes such as CCNE1, RAB25, MYC and NOTCH3. Phenotypic analysis of matched single-cell RNA sequencing data3 indicated pre-existing and clone-specific transcriptional states such as upregulation of epithelial-to-mesenchymal transition and VEGF pathways, linked to drug resistance. In one notable case, clone-specific ERBB2 amplification affected the efficacy of a secondary targeted therapy with a positive patient outcome. Together, our findings indicate that drug-resistant states in HGSOC pre-exist at diagnosis, leading to positive selection and reduced clonal complexity at relapse. We suggest these findings motivate investigation of evolution-informed adaptive treatment regimens to ablate drug resistance in future HGSOC studies. A combined sequencing technique assesses 18 patients with high-grade serous ovarian cancer over a multi-year period from diagnosis to recurrence and shows drug resistance typically arises from selective expansion of one or a few clones present at diagnosis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
淡淡熠彤发布了新的文献求助10
1秒前
1秒前
TYH发布了新的文献求助10
1秒前
1秒前
CaliU发布了新的文献求助10
2秒前
无无完成签到,获得积分20
2秒前
lwj完成签到,获得积分10
2秒前
Fatherrr发布了新的文献求助10
2秒前
北酱发布了新的文献求助10
2秒前
2秒前
GJIOOHFHN完成签到 ,获得积分10
2秒前
乐乐的应助被凉拌红烧肉采纳,获得10
4秒前
Zzz完成签到,获得积分10
4秒前
海石酸辣完成签到 ,获得积分10
4秒前
明亮的犀牛完成签到,获得积分10
4秒前
苗浩阳完成签到,获得积分10
4秒前
zyh9762发布了新的文献求助10
5秒前
5秒前
NexusExplorer的应助被WYH采纳,获得10
5秒前
星空发布了新的文献求助10
5秒前
wnw完成签到,获得积分10
5秒前
5秒前
圆圆完成签到,获得积分10
5秒前
6秒前
6秒前
MM完成签到 ,获得积分10
6秒前
6秒前
小铁的应助被白耀庭采纳,获得10
6秒前
高大的凝阳完成签到,获得积分10
6秒前
今后的应助被www采纳,获得10
6秒前
7秒前
Peiqi的应助被怡然的扬采纳,获得20
7秒前
7秒前
Mayday完成签到,获得积分10
8秒前
洁净的冬日完成签到,获得积分10
8秒前
9秒前
ZsJJkk发布了新的文献求助30
9秒前
周末完成签到 ,获得积分10
9秒前
9秒前
dus116完成签到,获得积分10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180531
求助须知:如何正确求助?哪些是违规求助? 9570507
关于积分的说明 21812974
捐赠科研通 7776619
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557539
邀请新用户注册赠送积分活动 2479185